GlobalRPh Renal Dosing Masterv6.6
Evidence addition

Taurolidine / heparin - DEFENCATH catheter lock

Local official-label summaryBase record retrieved 2026-09-10See the evidence for this drug2 sources available - open source summaries, references and comparisons

DEFENCATH / taurolidine heparin catheter lock

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)
Review first - source-specific qualification

Catheter-lock volume is not a systemic renal dose

The label and mirror specify catheter-lumen use and aspiration/discard before the next HD session.

Before applying: Use the catheter-specific volume and workflow. Do not turn failed aspiration guidance into permission for routine systemic flushing.

Evidence for this qualification

Selected-source qualification; independent clinician review pending.

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Official source

Taurolidine / heparin - DEFENCATH catheter lock

Product / population
Antimicrobial catheter lock for adults with kidney failure receiving chronic HD through a central venous catheter; not systemic heparin, systemic anti-infective therapy or a flush product.
Renal measure
Catheter lumen volume; no systemic renal-dose bands
Before using this finding

The failed-aspiration contingency must remain attached to the catheter protocol, not rewritten as a routine systemic flush.

Selected named sections only; not a complete monograph or independent clinical approval.

Selected exact-product labeling sections read. Original-source bytes and complete revision histories were not retained or reconciled; retrieval does not establish current product availability.

Renal dosing, restrictions and evidence limits

For the indicated adult chronic-HD CVC population, instill only into catheter lumens after HD. Determine the volume from the catheter specifications. Aspirate and discard the solution before the next HD treatment. If aspiration is unsuccessful, the label refers to standard catheter preparation using normal saline and the catheter-malfunction protocol; it is not general permission to flush the lock systemically. DEFENCATH is not a flush product or for systemic administration. The selected evidence does not establish use for every dialysis access or an eGFR-based regimen.

Source revision: 12/2024 | Retrieved: 2026-09-10. Retrieval date is not the revision date.

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-specific interpretation

What the dialysis evidence actually supports

Removal information alone does not define a maintenance dose, supplemental dose or dialysis schedule. A reported regimen still requires its product, indication, renal measure and dialysis assumptions to match the patient.

Taurolidine / heparin - DEFENCATH catheter lock

Authored v6.0; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

Catheter-lock workflow only - not systemic renal dosing

Read the source and its limits

GlobalRPh RX List - DEFENCATH

Authored v6.0; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

Catheter-lock workflow only - not systemic renal dosing

Read the source and its limits

These manual classifications apply only to the identified selected sections, not every retained source or the entire prescribing information. They are not dosing clearance.

Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

Official product label

Taurolidine / heparin - DEFENCATH catheter lock

Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.
Before using this finding

The failed-aspiration contingency must remain attached to the catheter protocol, not rewritten as a routine systemic flush.

Dialysis evidence: Catheter-lock workflow only - not systemic renal dosing

Antimicrobial catheter lock for adults with kidney failure receiving chronic HD through a central venous catheter; not systemic heparin, systemic anti-infective therapy or a flush product.

Renal method: Catheter lumen volume; no systemic renal-dose bands
Retrieved: 2026-09-10

Read local renal resultOpen original reference
GlobalRPh RX List

GlobalRPh RX List - DEFENCATH

Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.
Before using this finding

Confirm the catheter lumen volume and aspiration/discard workflow; do not prescribe the vial as a systemic dose.

Dialysis evidence: Catheter-lock workflow only - not systemic renal dosing

Antimicrobial catheter lock for adults with kidney failure receiving chronic HD through a central venous catheter; not systemic heparin, systemic anti-infective therapy or a flush product.

Renal method: Catheter lumen volume, not an eGFR or mg/kg renal algorithm
Retrieved: 2026-09-10

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-specific review points

Catheter-lock volume is not a systemic renal dose

Read the attributed comparison notes and source cards below. No conflict has been silently adjudicated.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

route and catheter workflow

Catheter-lock volume is not a systemic renal dose

The label and mirror specify catheter-lumen use and aspiration/discard before the next HD session.

How to use this: Use the catheter-specific volume and workflow. Do not turn failed aspiration guidance into permission for routine systemic flushing.

GlobalRPh RX List - DEFENCATHTaurolidine / heparin - DEFENCATH catheter lock

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeTaurolidine / heparin - DEFENCATH catheter lockGlobalRPh RX List - DEFENCATH
Choose two source checkboxes below.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Exact product and population

Product identity selected for the separately displayed source protocols below. Reference: https://globalrph.com/rx-list/defencath-drug/

Exact product and population

Antimicrobial catheter lock for adults with kidney failure receiving chronic HD through a central venous catheter; not systemic heparin, systemic anti-infective therapy or a flush product.

RDM60-SCOPE-taurolidine-heparin-defencath · Source section: Selected source product scopeRenal section finder
Separate U.S. product-label layer

FDA / DailyMed dosing and renal information

Official

Taurolidine / heparin - DEFENCATH catheter lock

Open original reference

Open / share this exact local source

DailyMed / CorMedix Inc. · Antimicrobial catheter lock for adults with kidney failure receiving chronic HD through a central venous catheter; not systemic heparin, systemic anti-infective therapy or a flush product.

Renal method: Catheter lumen volume; no systemic renal-dose bands
Source date: 12/2024
Retrieved: 2026-09-10

Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.
Before using this finding

The failed-aspiration contingency must remain attached to the catheter protocol, not rewritten as a routine systemic flush.

Dialysis evidence: Catheter-lock workflow only - not systemic renal dosing

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

For the indicated adult chronic-HD CVC population, instill only into catheter lumens after HD. Determine the volume from the catheter specifications. Aspirate and discard the solution before the next HD treatment. If aspiration is unsuccessful, the label refers to standard catheter preparation using normal saline and the catheter-malfunction protocol; it is not general permission to flush the lock systemically. DEFENCATH is not a flush product or for systemic administration. The selected evidence does not establish use for every dialysis access or an eGFR-based regimen.

RDM60-official-taurolidine-heparin-defencath-4db2fa17b4-C1 · Source locator: 1; 2.1-2.2; 4

Source-specific limits

Selected named sections only; not a complete monograph or independent clinical approval.

Selected exact-product labeling sections read. Original-source bytes and complete revision histories were not retained or reconciled; retrieval does not establish current product availability.

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6
Retrieved
2026-09-10
Exact label title
Taurolidine / heparin - DEFENCATH catheter lock
DailyMed Set ID
13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6
Labeler
CorMedix Inc.
Label revision
12/2024
Renal-function method
Catheter lumen volume; no systemic renal-dose bands
Source date/version
12/2024
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
c1b5b00cc1cda8764671d6c619e5c1d58fb9afbe7fb270142d30a7cd4e68ba0e
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - DEFENCATH

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Antimicrobial catheter lock for adults with kidney failure receiving chronic HD through a central venous catheter; not systemic heparin, systemic anti-infective therapy or a flush product.

Renal method: Catheter lumen volume, not an eGFR or mg/kg renal algorithm
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.
Before using this finding

Confirm the catheter lumen volume and aspiration/discard workflow; do not prescribe the vial as a systemic dose.

Dialysis evidence: Catheter-lock workflow only - not systemic renal dosing

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

The mirror describes catheter-lumen instillation after HD in the indicated adult CVC population. Match instilled volume to the catheter lumen, rather than treating vial size as the prescribed volume. Aspirate and discard before the next HD treatment. This is not systemic administration or a flush product. Heparin-induced thrombocytopenia and relevant component/pork-product hypersensitivity are contraindications. No renal systemic-dose conversion is supported by these instructions.

RDM60-rxlist-taurolidine-heparin-defencath-cac88f6967-C1 · Source locator: Indication; 2.1-2.2; contraindications

Source-specific limits

Selected named sections only; not a complete monograph or independent clinical approval.

A label mirror is not independent corroboration of its underlying label. See the separately attributed official source; concordance is limited to selected sections.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/defencath-drug/
Retrieved
2026-09-10
Renal-function method
Catheter lumen volume, not an eGFR or mg/kg renal algorithm
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
6c0838405a7e51ee9c2c0db2674d6b50e60078271054944342403456c054602c

Provenance and preservation

Additional summaries stored on this page: 1 official-label, 1 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/rx-list/defencath-drug/
Source retrieval
2026-09-10. This is not the source publication or label revision date.
Original source type
rxlist summary
Local text SHA-256
a02bcefb000773bac08cc94d931af5439e4273ed85a98d8874cca43eac10db57
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.

Read the full coverage report